Rare diseases
Investigational molecules
Locations
Back to Czechia15 clinical trials in Klecany, Czechia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
CzechiaPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
CzechiaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
CzechiaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
CzechiaLong-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
CzechiaStudy on Psilocybin, Ketamine, and Midazolam for Treating Depression in Cancer Patients
CzechiaStudy of psilocybin therapy for psychological distress in patients with COPD, ALS, multiple sclerosis, or atypical Parkinson's disorders
CzechiaEfficacy of Etifoxine in Adults with Adjustment Disorder with Anxiety: A Randomized, Double‑Blind, Placebo‑Controlled Trial
CzechiaCzechiaStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
CzechiaTesting Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment
CzechiaStudy on the Safety and Effectiveness of Aticaprant with Antidepressants for Adults and Elderly with Major Depressive Disorder
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on treatment-resistant depression and novel therapeutic approaches, including investigations of COMP360 and psilocybin-based treatments.
Multiple trials exploring adjunctive therapies and rapid-acting antidepressant interventions.
Comprehensive research examining treatments for neurodegenerative conditions and psychological distress in palliative care patients.
Studies focusing on improving quality of life and managing psychological symptoms in chronic conditions.
Targeted research addressing cancer-related depression and menopausal symptoms, with specific focus on comorbid conditions.
Evaluating novel compounds including elinzanetant and iclepertin for specific patient populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
